Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
TB-500 has been through Phase I and Phase II clinical trials of intravenous thymosin beta-4 with no serious adverse events reported in the published cohorts
By 72 days, the BPC-157 group showed consistent improvements across essentially every healing parameter: mechanical strength, functional recovery, macroscopic appearance, and microscopic tissue architecture
It supports tissue repair, inflammation modulation, and regenerative signaling across muscles, tendons, ligaments, and the gut lining, making it a focus for research in angiogenesis research, injury tissue remodelling, and wellness
Oral Supplements: High-dose B12 tablets may be prescribed if absorption is possible
Cob(II)alamin is then later converted into the other two forms, adenosylcobalamin and methylcobalamin for use as cofactors
Available at the pharmacy counter for in-store pickup
